Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a repurchase of 200,000 A-shares on 4 June 2026 via the Shanghai Stock Exchange for its A-Share Employee Stock Ownership Schemes.

• Transaction details – Shares repurchased: 200,000 – Volume-weighted average price: RMB 47.27 per share – Price range: RMB 47.05–47.45 – Aggregate consideration: RMB 9.45 million

• Capital structure impact (5 June 2026 closing balance) – Issued shares outstanding fell to 6,371.49 million, down 0.0031 % from the previous day. – Treasury shares rose to 7.52 million. – Total issued shares remained unchanged at 6,379.00 million, as the repurchased shares were shifted to treasury rather than cancelled.

Board authorisation and all regulatory requirements under the Hong Kong and Shanghai listing rules were confirmed as satisfied.